Syracuse (WSYR-TV) - A panel will now monitor any side effects from the H1N1 vaccine.
An independent group of experts appointed to help government officials monitor the swine flu vaccine's safety starts work Monday, the Associated Press reports.
Among its first tasks is to consider study data on the vaccine's effects in more than 10,000 people, according to the AP. So far, efforts to assess safety have turned up nothing unusual, Bruce Gellin, head of the National Vaccine Program Office, tells the AP, but it's important to be on the lookout for possible rare side effects.
Additional scrutiny of the H1N1 vaccine comes after the last vaccine to fight an outbreak of swine flu in 1976 was linked to Guillain-Barré syndrome, a rare disorder that results in paralysis.
